Suchergebnisse - "Ikeda, Shunya"

PubPharm (14)

1

Cost-effectiveness analysis of lemborexant for treating insomnia in Japan : a model-based projection, incorporating the risk of falls, motor vehicle collisions, and workplace accidents

enthalten in: Psychological medicine | 2022

von Ikeda, S. | Azuma, M. | Fujimoto, K. | +5

2

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

enthalten in: Journal of gastroenterology | 2019

von Kobayashi, M. | Kudo, M. | Izumi, N. | +7

3

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

enthalten in: Journal of gastroenterology | 2019

von Kobayashi, M. | Kudo, M. | Izumi, N. | +7

4

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

enthalten in: Journal of gastroenterology | 2019

von Kobayashi, M. | Kudo, M. | Izumi, N. | +7

5

Cost-effectiveness analysis of lenvatinib treatment for patients with unresectable hepatocellular carcinoma (uHCC) compared with sorafenib in Japan

enthalten in: Journal of gastroenterology | 2019

von Kobayashi, M. | Kudo, M. | Izumi, N. | +7

6

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

enthalten in: Journal of pharmaceutical health care and sciences | 2018

von Shimizu, H. | Suzuki, K. | Uchikura, T. | +12

7

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

enthalten in: Journal of pharmaceutical health care and sciences | 2018

von Shimizu, H. | Suzuki, K. | Uchikura, T. | +12

8

Economic analysis of palonosetron versus granisetron in the standard triplet regimen for preventing chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Japan (TRIPLE phase III trial)

enthalten in: Journal of pharmaceutical health care and sciences | 2018

von Shimizu, H. | Suzuki, K. | Uchikura, T. | +12

9

Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

enthalten in: BMC health services research | 2015

von Kikuchi, K. | Miyakawa, Y. | Ikeda, S. | +2

10

Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

enthalten in: BMC health services research | 2015

von Kikuchi, K. | Miyakawa, Y. | Ikeda, S. | +2